title: Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up.
abstract: OBJECTIVE
  To describe the pathologic characteristics and prognostic factors of primary breast sarcomas (PBSs).
  
  
  METHODS
  We reviewed the clinical records and pathologic slides of 83 women with PBS treated in our institution between 1954 and 1991, with a median follow-up of 7.8 years. The majority of patients had undergone surgical treatment.
  
  
  RESULTS
  The main histologic type was malignant fibrohistiocytoma (n = 57). For the whole population, the 10-year overall survival (OS) and disease-free survival (DFS) rates were 62% and 50%, respectively. For Fédération Nationale des Centres de Lutte Contre le Cancer grade 1, 2, and 3 tumors, the 10-year OS and DFS rates were 82% and 61%, 62% and 51%, and 36% and 25%, respectively (P =.00007 and.004, respectively). For tumors measuring less than 5 cm, 5 to 10 cm, and more than 10 cm, the 10-year OS and DFS rates were 76% and 66%, 68% and 55%, and 28% and 15%, respectively (P =.002 and.009, respectively). In the multivariate analysis, the tumor size and histologic grade were correlated with the 10-year DFS rate (P =.04 and.01, respectively), but only the histologic grade was correlated with OS (P =.01). Angiosarcoma was the only histologic type significantly associated with a poorer outcome in the multivariate analysis.
  
  
  CONCLUSIONS
  PBSs have the same clinical history and prognostic factors as sarcomas arising at other sites. Therefore, it is legitimate to use a similar treatment strategy for PBS as for other sarcomas.
authors.affiliation: Department of Medicine, Institut Gustave-Roussy, Villejuif, France. laurent.zelek@hmn.ap-hop-paris.fr
authors.forename: L
authors.initials: L
authors.lastname: Zelek
authors.forename: A
authors.initials: A
authors.lastname: Llombart-Cussac
authors.forename: P
authors.initials: P
authors.lastname: Terrier
authors.forename: X
authors.initials: X
authors.lastname: Pivot
authors.forename: J M
authors.initials: JM
authors.lastname: Guinebretiere
authors.forename: C
authors.initials: C
authors.lastname: Le Pechoux
authors.forename: T
authors.initials: T
authors.lastname: Tursz
authors.forename: F
authors.initials: F
authors.lastname: Rochard
authors.forename: M
authors.initials: M
authors.lastname: Spielmann
authors.forename: A
authors.initials: A
authors.lastname: Le Cesne
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008499:Medical Records; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D012509:Sarcoma / Q000473:pathology* / Q000628:therapy